Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

NCT00753207 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: epirubicin hydrochloride
DRUG: lapatinib ditosylate
OTHER: biomarker analysis
OTHER: immunohistochemistry staining method
OTHER: liquid chromatography
OTHER: mass spectrometry

Sponsor

Cancer Trials Ireland